Dr. Yianni Psaltis is a Managing Director at Exponential Ventures (XPV). An entrepreneur, investor, and trusted advisor, Dr. Psaltis brings a wealth of experience in building, guiding, and scaling innovative companies across AI, biotech, and energy sectors.

Previously, Dr. Psaltis held the prestigious role as "Strike Force" Entrepreneur-in-Residence at PHD Ventures, serving as Dr. Diamandis' primary thought partner where he played a strategic advisory role for XPRIZE Healthspan, BOLD Capital Partners, Fountain Life, and Singularity University. He was also the primary curator of Dr. Diamandis' exclusive Longevity Platinum Trips. Alongside Dr. Diamandis, Dr. Psaltis has co-advised numerous cutting-edge companies, including Insilico Medicine, Haute.AI, Colossal Biosciences, Openwater, and Immunis, providing critical support and strategic guidance to accelerate their missions.

Through his work as an entrepreneur and investor, Dr. Psaltis has engaged with a wide array of global leaders, spanning governments, institutions, and investors. In collaboration with Dr. Diamandis, he has advised renowned business leaders and world authorities on the transformative potential of AI and other exponential technologies across sectors, with a particular emphasis on applications to human well-being and healthspan.

Dr. Psaltis' passion for driving innovation is rooted in his interdisciplinary research background at the nexus of cellular and molecular biology, biochemistry, and cancer biology. His doctoral thesis at Georgetown University focused on uncovering novel therapeutic mechanisms for breast cancer patients suffering from heavy metal exposure.

Dr. Psaltis earned his BS in Biology from Boston College, followed by an MS in Biotechnology and a PhD in Cancer Biology from Georgetown University. Driven by the transformative power of science and technology, he is dedicated to advancing AI-driven solutions that improve lives and elevate the human condition. Outside of work, he enjoys optimizing his own well-being during summers in Greece.